Related by context. All words. (Click for frequent words.) 79 ratio 59 Ratios 56 Ratio 53 #.#x #.#x [002] 52 pro forma MADS 51 P TBV 51 analyzed tooth enamel 50 h Represents 50 Leverage ratios 50 dividend payout ratios 50 payout ratios 49 adequacy ratios 49 assets ratio CRAR 49 Specialized REITs industry 49 ROAs 49 Quarterly Periods 48 BBB medians 48 capitalized minimums 48 Risk Weighted 48 multiples 47 PE ratios 47 NPL ratios 47 cyclically adjusted 47 Fitch BBB medians 47 .#:# 47 LTV ratios 47 aP S 47 RoEs 47 KPIs metrics 47 strategies KPIs metrics 47 Diversified REITs industry 47 Leverage Tier 46 PEG ratios 46 NOI DSCR 46 ROE 46 Capital Adequacy Ratio 46 securitization exposures 46 DCOH 46 adequacy ratio 46 strontium isotope naturally occurring 46 ROEs 46 MCCSR 46 EBIDA 46 provisioning norms 46 BIS Tier 45 valuation multiples 45 valuation metrics 45 assets RoA 45 TCE ratio 45 #.#x [003] 45 lapsation 45 weightages 45 DSCRs 45 TCE TA 45 Negative Rating Outlooks 45 ROACE 45 odds ratios ORs 45 rates 45 ratios compare favorably 45 Homefurnishing Retail industry 45 #.#:# #.#:# [001] 44 equity RoE 44 Funded Debt 44 #.#x #.#x #.#x #.#x [003] 44 equity ROE 44 overcollateralization OC ratios 44 CIRe 44 CRAR 44 ROAA 44 Leverage Ratio 44 #.#X [003] 44 Price Profitability Liquidity 44 value ratios LTVs 44 coverage ratios DSCRs 44 ECVT modes 44 metrics 44 Nifty PCR 44 average equity ROAE 44 quintiles 44 PERs 44 PE ratio 43 levels 43 PE multiples 43 #x #x [001] 43 variable annuity guarantees 43 RDIs 43 MADS coverage 43 solvency ratios 43 REGULATORY CAPITAL DATA 43 normalized EPS 43 quartiles 43 4x 5x 43 Financial Ratios 43 Industrial Conglomerates industry 43 #.#x DSCR 43 Direxion ETFs 43 #.#:# #.#:# #.#:# [002] 43 Ratio BCAR 43 BCAR 43 VaR calculations 43 P Es 43 ttm 43 P/E# 43 correlation coefficients 43 Total Expense Ratio 43 ratio #.#:# #.#:# 43 #.#x #E [002] 43 #.#:# [006] 43 SBLIC 43 PUTs 43 glutamate glutamine 42 adv dec ratio 42 deciles 42 Lonpac 42 ROAE 42 covenant calculations 42 TFG CLO investments 42 Capital Adequacy 42 Solvency Score 42 stressed DSCR 42 TERs 42 Positive Outlooks 42 Invested Capital 42 #.#x #.#x [001] 42 Cash Flow Cushion 42 RoE 42 capitalisations 42 Conglomerates sector 42 #.#x #.#x [004] 42 pro forma MADS coverage 42 Solvency ratio 42 Assets ROA 42 #.# DCOH 42 gross NPL ratio 42 kurtosis 42 deduplication ratios 42 Leverage ratio 42 Expense ratios 42 NAIC RBC 42 aP E ratio 42 fiscals #-# 42 #:# #:# [001] 42 Leverage Ratios 42 QGIR 42 policyholder retention 42 Strength Ratings 42 #.#x [006] 42 CLO tranches 42 ROE ROA 42 EPADS estimate 42 comparably rated 41 RONW 41 nonrated 41 value LTV ratios 41 ROICs 41 hemoglobin concentrations 41 Sharpe Ratios 41 reciprocals 41 AA medians 41 Asset Utilization 41 Interest Coverage Ratio 41 MLRs 41 #:# #:# [005] 41 #.#x #E [001] 41 Fitch DSCR 41 STERIS calculation 41 pe ratios 41 NIMs 41 Price Strength Rating 41 annualized ROA 41 SHFAs 41 #.#x #.#x [003] 41 A#/P# 41 EV EBITDA multiples 41 HMFI 41 Loss Severity 41 Tangible Common Equity 41 overcollateralization ratios 41 category medians 41 covenant ratios 41 FY#F 41 remarkable #,#:# contrast 41 Capital Ratios 41 REIT TruPS CDOs 41 policyholder dividends 41 Gross NPAs 41 ratio MLR 41 #:# dynamic contrast 41 average assets ROAA 41 ~ #x 41 elasticities 41 Baa rated 41 helium isotopes 41 Sharpe Ratio 41 Realized Earnings 40 CY# EPS estimate 40 statutory minimums 40 scf bbl 40 #,#,#:# dynamic contrast [002] 40 FCBs 40 LTM EBITDA ratio 40 Tangible Common 40 Deposit Ratio 40 #:# [011] 40 #,#:# dynamic 40 waist circumference measurements 40 #e EPS 40 '#E EPS 40 obligor concentration 40 skewness 40 SHKPI 40 IRRs 40 Multivariable 40 RNBCs 40 gross NPAs 40 liquidity buffers 40 THB# #mn 40 CREL CDO 40 Unfunded liabilities 40 guaranty insurers 40 overcollateralization OC tests 40 FY#E EV EBITDA 40 #.#:#.# [003] 40 nonperforming loans NPLs 40 Tangible Equity 40 Realised Earnings 40 Gini coefficients 40 Coverage Ratio 40 percentages 40 LTM adjusted EBITDA 40 interest margins NIMs 40 • Compounded singles 40 Best Capital Adequacy 40 divisors 40 #x FY# 40 precrisis 40 CAMELS rating 40 Performance Ratios 40 MRQ 40 Cronbach alpha 40 interest margin NIM 40 lifecos 40 FMBI 40 XLP SPY Relative Strength 40 RAROC 40 EBTIDA 40 MARTEN TRANSPORT LTD 40 collateralization OC 40 SEIs 40 #.#x FY#E earnings [002] 40 NOTES Applicable 40 widescreen #.#:# aspect 40 deuterium hydrogen 40 Equity indexed annuities 40 #:# contrast [002] 40 -planting saplings 40 #.#x [007] 40 Compounded singles 40 #-# bps 40 undepreciated book 40 #.#x FY#E ABV [002] 40 dividend payout ratio 40 covenant headroom 39 Indexed annuities 39 indenture covenants 39 Caa1/CCC + 39 overcollateralisation 39 capital employed ROACE 39 efficiency ratio teb 39 MCCSR ratio 39 Cr Fe 39 repayment IBR 39 #.#x FY#E P 39 FHCs 39 standard deviations 39 nonaccruing loans 39 AFFO payout ratio 39 #.#X FY# [001] 39 NIPPONKOA Asia 39 museum Julie Setlock 39 RfD 39 CRE CDOs 39 RVUs 39 inhospital mortality 39 MADs 39 capitalization 39 brightness #:# contrast 39 Capital Ratio 39 EUR#.#b 39 undepreciated assets 39 admissions selectivity 39 cheapest quintile 39 confidence intervals CIs 39 diluted FAD 39 histograms 39 indicators 39 indictors 39 CDO financings 39 balance sheets 39 #.#:# [001] 39 Descriptive statistics 39 Payout ratios 39 Westamerica Bancorp 39 Recovery Ratings RRs 39 rated CREL CDOs 39 ISTEP Plus scores 39 PTPP 39 EBIDTA margins 39 CRE exposures 39 ap e 39 BVPS 39 Dividend Payout Ratio 39 upper quartile 39 Nifty OI 39 PANHANDLE Soil moisture 39 Medicare Advantage MLR 39 CENTRAL Soil moisture 39 thresholds 39 financeability 39 solvency ratio 39 #.#cps [002] 39 SLHCs 39 2x 3x 39 CFNAI 39 #.#x EV 39 Aaa rated 39 Surplus Requirements MCCSR 39 #.#x #.#x #.#x #.#x [002] 39 EARNINGS Taxable equivalent 39 backtests 39 procyclical 39 assets ROA 39 Zometa hazard 39 FY#E [001] 39 Minimum Continuing 39 Option ARMS 39 TED Spread 39 logarithmic scale 39 mortality morbidity 39 BHCs 39 IAS# HPI 39 TIPS breakevens 39 LTV ratio 39 Stable Outlooks 39 Taxable Equivalent Basis 39 TTM EPS 39 payout ratio 39 multivariate adjusted 38 MCEV 38 FY#E EPS [002] 38 isoflavone intake 38 #.#:# #.#:# [003] 38 Soil moisture levels 38 NPV IRR 38 Mg Li 38 SRFs 38 weightings 38 Annualized 38 ROIC 38 prudential norms 38 highly correlated 38 Specialty Admitted segment 38 ROCE 38 relativities 38 dealer floorplan ABS 38 #.#X [001] 38 XLI SPY Relative Strength 38 Negative Outlooks 38 serum PTH 38 OPEB obligations 38 #.#x FY# [003] 38 lev els 38 overgeared 38 decibel dB 38 Capital Employed 38 #.#x FY#E [003] 38 nonperforming assets NPAs 38 #.#x EV EBITDA [001] 38 Invested Capital ROIC 38 fi gures 38 adjusted 38 VaR 38 Small Ordinaries Index 38 covenants contained therein 38 #:# ratio [002] 38 Apgar scores 38 logistic regression models 38 Total Leverage Ratio 38 2D 4D length 38 SCBs 38 MERs 38 Moyeen Islam fixed 38 engine rpms 38 FFO FAD 38 hsCRP levels 38 mitigants 38 quiescent currents 38 heavier weighting 38 Historical Volatility 38 Ebitda margins 38 staffing ratios 38 HbA1C levels 38 farebox recovery 38 3x 4x 38 mean ± SEM 38 omega fats 38 FCDUs 38 linear regression 38 prevalences 38 service MADS 38 VSWR 38 #.#x FY#E earnings [001] 38 #E EV EBITDA 38 hydrolytic stability 38 factor WARF 38 #.#:# widescreen aspect 38 ratio LVR 38 noninterest expense divided 38 Stonemor Partners NASDAQ STON 38 Closely spaced 38 Fitch Negative Outlook 38 macrosomia 38 tablets #:#:# 38 standard deviation 38 Basel III norms 38 conditional logistic regression 38 EDITDA 38 #bp QoQ 38 loan NPL ratio 38 positively sloped 38 LIBOR indexed 38 consolidated OIBDA 38 Lehman Aggregate 38 LTM EBITDA 38 borrower creditworthiness 38 Annualized ROE 38 Standardized Approach 38 logistic regressions 38 trust preferreds 38 #.#x FY# [004] 38 overcollateralisation OC 38 LONG TERM TREND 38 logistic regression model 38 #.#:# [008] 38 #x FY# EPS 38 prepregnancy BMI 38 serum lipid 38 #E EBITDA 38 Logistic regression 38 2D 4D 38 PEG ratio 38 SOUTH Soil moisture 38 materiality threshold 38 urodynamic parameters 38 Nasdaq adv dec 38 Leveraged loans 38 rate 38 Caa 38 risk premia 38 Value LTV 38 #.#x FY# [001] 38 net chargeoffs 38 retrospectively adjusted 38 #/#ths inch 37 preprovision 37 Annualised 37 Breakevens 37 Supplemental Schedules 37 Renaissancere 37 fluid viscosity 37 PDP MLR 37 hand DCOH 37 cyclically depressed 37 Balance sheet 37 investability 37 PDSs 37 CY#E EPS 37 Expense Ratio 37 Expense Ratios 37 rating affirmations 37 flyback converters 37 maturity YTM 37 FCCR 37 ResiLogic model 37 delevered 37 Indicators 37 linear extrapolation 37 beta coefficient included 37 performing loans NPLs 37 PSA kinetics 37 #.#:# #.#:# #.#:# [001] 37 overcollateralization OC 37 Commodity Chemicals 37 Crisa acquisition 37 oxygen saturations 37 Shanda Interactive NASDAQ SNDA 37 g secs 37 FRMs 37 FYE# 37 FY#E ABV 37 VaR calculation 37 Ba2 rating 37 #.#x FY#E ABV [001] 37 NIM compression 37 MIICL 37 CRE concentrations 37 Shareholder Return 37 Finviz 37 reprices 37 Advancers trounced decliners 37 #.#x FY#E [004] 37 macroeconomic variables 37 collateralization 37 noncurrent loans 37 #E EPS 37 breakevens 37 microcap segment 37 FAR WEST Soil moisture 37 EV FCF 37 Kt V 37 Chubb CB 37 Lipper peer 37 LAE reserves 37 Cash Flow Statements 37 nonGAAP 37 MPRs 37 proforma 37 releveraging 37 profitabilty 37 International NASDAQ HSII 37 multivariate regression analysis 37 COASTAL BEND Soil moisture 37 #.#x [004] 37 Unleveraged 37 mmcf equivalent 37 nmol L. 37 similarly captioned 37 Sensitivity analyzes 37 Stock Upgrades Downgrades 37 NOPAT 37 reproducible measurements 37 percentiles 37 #:# aspect ratios 37 #.#x FY#E EV EBITDA [002] 37 MMRs 37 NPVs 37 un levered 37 dimensional sonography 37 cashflows 37 Calorie intake 37 Waist Hip 37 invisibles surplus 37 -#.# log# 37 assigned Rating Outlooks 37 BMI z 37 Joseph Piotroski benchmark 37 TC HDL 37 Equity ROE 37 McDep Ratio 37 multivariable adjusted 37 computed 37 Percentage Yield APY 37 weighted average 37 valuations 37 FICOs 37 LVRs 37 balance sheet 37 maturity mismatches 37 Return TSR 37 Rating Methodology 37 OCF margin 37 IBDQ 37 6x FY#E 37 banksâ € ™ 37 Efficiency Ratio 37 #.#x MADS [001] 37 DTVH 37 Loss severities 37 CMBS collateral 37 assets ROAA 37 #x [003] 37 earnings pershare 37 intraclass correlation coefficients 37 subordination overcollateralization 37 pretest probability 37 structural subordination 37 origination volumes 37 #.#X [002] 37 Residential REITs 37 serum magnesium 37 CNAF 37 GDX GDXJ 37 countercyclical buffer 37 echocardiographic parameters 37 voltage derating 37 Fitch AAAmmf rating 37 excluding AOCI 37 TFG CLO 37 measurements 37 deductibles copays 37 UNITED COMMUNITY BANKS INC. 37 refracture 37 insula activation 37 rigid PCBs 37 QIS4 37 HGNSI 37 Implied Volatility 37 overcollateralization 37 Transsib Re 37 overcollateralization tests 37 cross sectionally 37 CREL CDOs 37 stabilities 37 Volatility Percentile 37 estimated GFR 37 CY# EPS 37 FYE# FYE# 37 Assets NPAs 37 #:# #:# [003] 37 Kleros RE IV 37 Reuters pages SIFO 37 normalized 37 borrowable funds 37 multiline insurers 37 cytologic 37 Baseline characteristics 37 noise ratio SNR 37 Losers outnumbered winners 37 unfavorable payor mix 37 BMI percentiles 37 lognormal 37 xi unanticipated 37 prudential requirements 37 Risk VaR 37 perinatal outcomes 37 myocardial blush 37 ionotropic 37 interobserver reliability 37 Duration Gap 37 condensed consolidated balance sheets 37 stepwise logistic regression 37 rebalanced annually 37 #bps qoq [002] 37 NCAV 37 Munghana Lonene Listenership 37 c Calculated 37 self insured retentions 37 pd ratings 37 Libor OIS 37 backtest 36 subordinate tranches 36 website www.bancroftfund.com 36 Euribor fixings 36 Pledged revenues 36 written NPW 36 widescreen #:# 36 RBC transfusions 36 elevated LDH 36 Management Expense Ratios 36 Assessment BCA 36 camshaft profiles 36 lenders SVRs 36 Lease Losses ALLL 36 #.#x FY#E [001] 36 Net Profit Margin 36 BRE Properties BRE 36 threshold voltages 36 buck converters 36 th percentile 36 MNMC 36 #bp #bp [003] 36 #.#x #.#x #.#x #.#x [001] 36 Protected Withdrawal Value 36 RRs 36 assigned Stable Outlooks 36 #/#mmHg 36 operating netback 36 LTVs 36 Assets Ratio 36 SEER seasonal 36 & Consumable Fuels 36 IFRS changeover 36 Medcohealth Solutions 36 HBOS.L 36 ANCOVA 36 A' rated 36 retractable stylus 36 Statutory Liquidity Ratio 36 actuarially determined 36 Aaa ratings 36 PWM dimming 36 #.#-#.# bln dkr [002] 36 undemanding valuations 36 #,#:# dynamic contrast [001] 36 nonaccruals 36 service MADS coverage 36 WikiWealth.com s 36 TIMELINE Changes 36 IDIs 36 #.#:# rear axle 36 phthalate metabolites 36 decile 36 RTO RPO 36 Linear regression 36 Repeatability 36 HG LV 36 Physical Component 36 classifications 36 analysis Innovest IVA 36 annualizes 36 AMR CORPORATION CONSOLIDATED 36 nominal GDP 36 Horses previewed 36 FY# EV EBITDA 36 Asterisks indicate 36 LTM Adjusted EBITDA 36 Associated Banccorp 36 actuarial calculations 36 Spousal Highest Daily 36 RRIF withdrawal 36 NPL ratio 36 CI #.#-#.# [001] 36 achieving hemostasis 36 footnote disclosures 36 non gaap 36 RMBS CMBS 36 strontium isotope 36 #c #c [002] 36 overexposures 36 fourinterim periods 36 nitrogen isotopes 36 Key Stats 36 NNRTI resistant virus 36 infla tion 36 Approximations 36 LDL HDL 36 EMEA CMBS 36 numerator 36 beta coefficient 36 serum testosterone levels 36 Recovery Ratings 36 DPAC amortization 36 expiratory flow 36 #.#:# [002] 36 TheStreet.com Ratings 36 temperature coefficients 36 tier1 36 overbought oversold 36 various leTTeRz 36 densities 36 HDFC Taxsaver 36 ABX indices 36 PNNT 36 AFLIC 36 HCBK 36 Maintain Neutral 36 redefault 36 LDRs 36 Illiquidity 36 Issuer Default Ratings IDRs 36 vitamin D metabolites 36 peak VO2 36 FINDEP 36 coincident composite index 36 abdominal circumference 36 subscores 36 selectivities 36 Gentle EVER 36 FY1 36 % CI #.#-#.# [008] 36 deleverages 36 % Confidence Interval 36 WSFG 36 Casiopea Re 36 Meta analyzes 36 assessed valuation AV 36 symptomatic intracranial hemorrhage 36 Banking Supervision Basel III 36 dB insertion loss 36 Thomson Reuters StarMine 36 corresponding reconciliations 36 Well Capitalized 36 LMGI 36 XLF SPY Relative Strength 36 Unlevered 36 COGP 36 FFNW 36 Banker Acceptances 36 mso font pitch 36 Mapfre Re 36 SmartGrowth deposits 36 Generally Accepted Accounting Principle 36 readily determinable 36 nonwage 36 Decile 36 coverage ratios DSCR 36 Demographic trends 36 weighted avg 36 dose Iluvien 36 Contrast Ratio 36 SOIR readings 36 Carreker Corporation improves 36 Condition Classification 36 Consistent Return 36 anogenital distance 36 #.#x respectively 36 Diversified Chemicals 36 PSBs 36 #.#x FY#E EV EBITDA [001] 36 many Swazis revere 36 operating EBIDA 36 PLAR 36 covariate 36 IBNR 36 DepositAccounts.com 36 Value EV 36 Icici Bank 36 defined shallowly dipping 36 OFZ curve 36 AFG Intrinsic Value 36 inattention hyperactivity 36 PLRs 36 Percentage Rate 36 Supplementary Table 36 Statistical Tables 36 Otelco AMEX OTT 36 Ashworth Scale 36 CFNAI MA3 36 waist girth 36 downstreamed 36 CY#E [002] 36 IPCRe 36 TBV 36 REGULATORY CAPITAL 36 variograms 36 IXJ 36 multivariate regression 36 TCE RWA ratio 36 ultrashort bond 36 serum sodium concentration 36 ± SEM 36 UAAL 36 flatter yield curve 36 Re.1 thereafter 36 operating netbacks 36 Swap spreads 36 MFFO 36 Banking Supervision BCBS 36 TRIN 36 NCO GROUP INC. 36 #.#x FY# [002] 36 albumin excretion 36 calcium phosphorus 36 #:# #:# [004] 36 BFSRs 36 Relative Strength Rating 36 mimicked saliva 36 unlevered balance sheet 36 Knightsbridge Tankers NASDAQ VLCCF 36 units RVUs 36 undesignated reserves 36 aircraft separation RVSM 36 BSRR 36 tertiles 36 #.#X zoom 36 performing obligors 36 IBIs 36 carbon isotopes 36 PV originations 36 NORTH Soil moisture 36 Adjustment Expenses 36 #.#-#.# [011] 36 receivables payables 36 Genworth Financial NYSE GNW 36 hourly stochastic 36 pulmonary capillary wedge 36 preferably conversant 36 RBC transfusion 36 Loss Ratios 35 Monro Muffler NASDAQ MNRO 35 subtotals 35 XLU SPY Relative Strength 35 jumbo adjustable IO 35 μg liter 35 LDL triglycerides 35 affirmations reflect 35 QRMs 35 expenditure capex 35 ACR ReTakaful SEA 35 concessional contributions 35 NOTAM text 35 windows Vorak 35 borrower depositor 35 birthweights 35 unobservable inputs 35 permanently discontinue Vectibix 35 Fitch Issuer Default 35 per enplanement CPE 35 pulmonary exacerbations 35 #.#MHz switching frequency [001] 35 EEV 35 Loss Severity LS 35 reserve reestimates 35 balance sheet deleveraging 35 Fixed Charge 35 CoLTS #-# 35 FY# #E [002] 35 assigned Negative Outlook 35 Implied Offer 35 hemoglobin A1c levels 35 SEMCAN seeks 35 reweighted 35 rated tranches 35 Equity RoE 35 ITBS scores 35 Accumulation Distribution 35 NEUTRAL rating 35 Mental Component 35 #.#x FY#E EPS [003] 35 SNR signal 35 interrater 35 QR #.#bn 35 oxyhemoglobin 35 #.#ppts 35 #rd percentile 35 repo counterparties 35 HOMA IR 35 debt paydown 35 OFIX 35 XLK SPY Relative Strength 35 Itraxx 35 demographic subgroups 35 HSMR 35 MSCI EM Index 35 FQPA 35 AST ALT 35 Downward revisions 35 China Gerui 35 NPLs 35 levered balance sheets 35 redefaults 35 loan disbursals 35 market capitalisations 35 Los Chorros recover 35 NAVs 35 FINANCIAL HIGHLIGHTS Continued 35 ACGL 35 #Y yield 35 EBIAT 35 CMBS CDO 35 chasers motivations 35 BPLRs 35 Impairment Expense 35 Reinsurance Assumed 35 HRQL 35 restrictive covenants contained 35 AAA sovereigns 35 observable behaviors 35 Adequately Capitalized 35 PSRR 35 6 Mcf 1bbl 35 LQD TLT Relative Strength 35 elevated testosterone epitestosterone 35 Visit www.transre.com 35 FY# PER 35 allele frequencies 35 DHHA 35 EAST TEXAS Soil moisture 35 Miscellaneous Manufacturing 35 #:#,# [001] 35 Coumarianos 35 accounts receivable balances 35 Molex NASDAQ MOLXA 35 Assumed Reinsurance 35 SO8 package 35 Cpk 35 negative preannouncements 35 femoral component 35 Regression analysis 35 Loan Delinquency 35 intraclass correlation coefficient 35 Imputed Revenue 35 ALLL 35 Bracketed figures 35 excluding reimbursables 35 FY#e 35 EQAO tests 35 redefault rates 35 Asset Quality 35 serum aminotransferase levels 35 Immediate annuities 35 serum concentrations 35 SS NOI helps 35 HLCs 35 d Calculated 35 CMHC insured mortgages 35 Dividend Achievers 35 QIS5 35 QIDS SR